Literature DB >> 14684497

The EUROCARE Study: strengths, limitations and perspectives of population-based, comparative survival studies.

F Berrino.   

Abstract

Mesh：

Year:  2003        PMID： 14684497     DOI： 10.1093/annonc/mdg750

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  11 in total

1.  Predictive and prognostic clinical and pathological factors of nivolumab efficacy in non-small-cell lung cancer patients.

Authors:  J Garde-Noguera; P Martin-Martorell; M De Julián; J Perez-Altozano; C Salvador-Coloma; J García-Sanchez; A Insa-Molla; M Martín; X Mielgo-Rubio; S Marin-Liebana; A Blasco-Cordellat; S Blasco-Molla; R Gironés; D Marquez-Medina; F Aparisi; M C Bas Cerda; S Macia-Escalante; A Sánchez; O Juan-Vidal
Journal:  Clin Transl Oncol       Date:  2018-01-24       Impact factor: 3.405

Review 2.  Explanations for worsening cancer survival.

Authors:  Esther de Vries; Henrike E Karim-Kos; Maryska L G Janssen-Heijnen; Isabelle Soerjomataram; Lambertus A Kiemeney; Jan Willem W Coebergh
Journal:  Nat Rev Clin Oncol       Date:  2010-01       Impact factor: 66.675

3.  Inter-country and ethnic variation in colorectal cancer survival: comparisons between a Philippine population, Filipino-Americans and Caucasians.

Authors:  Maria Theresa Redaniel; Adriano Laudico; Maria Rica Mirasol-Lumague; Adam Gondos; Gemma Uy; Hermann Brenner
Journal:  BMC Cancer       Date:  2010-03-16       Impact factor: 4.430

4.  Outcome of teenagers and young adults with ependymoma: the Royal Marsden experience.

Authors:  Lucas Moreno; Francisco Jose Bautista; Stergios Zacharoulis
Journal:  Childs Nerv Syst       Date:  2009-06-16       Impact factor: 1.475

5.  The role of radiotherapy in the treatment of newly diagnosed supratentorial low-grade oligodendrogliomas: comparative analysis with immediate radiotherapy versus surgery alone.

Authors:  Hyun-Cheol Kang; Il Han Kim; Keun-Yong Eom; Jin Ho Kim; Hee-Won Jung
Journal:  Cancer Res Treat       Date:  2009-09-28       Impact factor: 4.679

6.  Evidence against the proposition that "UK cancer survival statistics are misleading": simulation study with National Cancer Registry data.

Authors:  Laura M Woods; Michel P Coleman; Gill Lawrence; Jem Rashbass; Franco Berrino; Bernard Rachet
Journal:  BMJ       Date:  2011-06-09

7.  Ovarian cancer survival population differences: a "high resolution study" comparing Philippine residents, and Filipino-Americans and Caucasians living in the US.

Authors:  Maria Theresa M Redaniel; Adriano Laudico; Maria Rica Mirasol-Lumague; Adam Gondos; Gemma Leonora Uy; Jean Ann Toral; Doris Benavides; Hermann Brenner
Journal:  BMC Cancer       Date:  2009-09-24       Impact factor: 4.430

8.  The hospital burden of disease associated with bone metastases and skeletal-related events in patients with breast cancer, lung cancer, or prostate cancer in Spain.

Authors:  R D Pockett; D Castellano; P McEwan; A Oglesby; B L Barber; K Chung
Journal:  Eur J Cancer Care (Engl)       Date:  2010-11       Impact factor: 2.520

9.  Provision of breast cancer care and survival in Germany - results from a population-based high resolution study from Saarland.

Authors:  Bernd Holleczek; Hermann Brenner
Journal:  BMC Cancer       Date:  2014-10-10       Impact factor: 4.430

10.  Increasing Disadvantages in Cancer Survival in New Zealand Compared to Australia, between 2000-05 and 2006-10.

Authors:  J Mark Elwood; Phyu Sin Aye; Sandar Tin Tin
Journal:  PLoS One       Date:  2016-03-03       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.